Endogenous granulocyte colony-stimulating factor (G-CSF) levels in chemotherapy-induced neutropenia and in neutropenia related with primary diseases

Journal of Experimental and Clinical Cancer Research

Volumn 21, Issue 4, 2002, Pages 475-479

  Kavgaci, Halil ^a   Ozdemir, F ^a   Aydin, F ^a   Yavuz, A ^a   Yavuz, M ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Chemotherapy; Granulocyte colony stimulating factor; Neutropenia

Indexed keywords

ANTINEOPLASTIC AGENT; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADULT; APLASTIC ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKOCYTE COUNT; MALE; MYELODYSPLASTIC SYNDROME; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH CARCINOMA; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMOGLOBINS; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPENIA; PLATELET COUNT; REFERENCE VALUES;

EID: 0036996290     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Piguet D., Chaguis B.: Recombinant human Granulocyte-Macrophage colony-stimulating factor in acquired or chemotherapy-induced neutropenia. Acta Oncol. 33 (6): 639-643, 1994.
2. Morstyn G., Campbell L., Souza L.M.,et al: Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet. 1: 667, 1988.
3. Welte K., Gabrilowe J., Bronchud M.H., Platzer E., Morstyn G.: Filgrastim (r-met Hu G-CSF): The first 10 years. Blood. 88 (6): 1907-1929, 1996.
4. Harmenberg J., Hoglund M., Hellstrom L.E.: G- and GM-CSF in oncology and oncological heamotology. Eur. J. Heamotol. 52: 1-28, 1994.
5. Cebon J., Layton J.E., Maher D., Morstyn G.: Endogenous heamopoietic growth factors in neutropenia and infection. Br. J. Heamatol. 86: 265-274, 1994.
6. Petros W.P., Peters W.P.: Colony-stimulating factors. In: Canbner BA., Longo DL., eds. Cancer chemotherapy and Biotherapy. 2nd edition, Philadelphia: Lippincott 1956: 639-654.
7. Greendyke R.M., Sharma K., Gifford F.R.: Serum cytokine levels in patients with neutropenia. Arch. Pathol. Lab. Med. 118 (2): 1193-1195, 1994.
8. Omori F., Okamura S., Shimoda K., et al.: Levels of human serum granulocyte colony-stimulating factor and granulocytemacrophage colony-stimulating factor under pathological conditions. Biotherapy 4 (2): 147-153, 1992.
9. Groopman J.E., Molina J.M., Scadden D.T.: Hematopoietic growth factors. Biology and clinical applications. N. Engl. J. Med. 321 (21): 1449-1459, 1989.
10. Griffin J.D.: Hematopoietic growth factors. In: De Vita VT Jr, Hellman S, Rosenberg SA.,eds. Cancer principles and practice of oncology. 5th edition, Philadelphia: Lippincott 1997: 2639-2657.
11. Watari K., Asano S., Shirafuji N et al.: Serum granulacyte colony-stimulating factor levels in healty volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 73 (1):117-122, 1989.
12. Sallerfors B., Olofson T.: Granulocyte-macrophage colonystimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukemia. Br. J. Haematol. 78 (3): 343-351, 1991.
13. Mizuno Y., Hara T., Nagata M., et al.: Serum granulocyte colony-stimulating factor levels in chronich neutropenia of infancy. Pediatr. Hematol. Oncol. 7 (4): 377-381, 1990.
14. Yujiri T., Shinohara K., Kurimoto F.: Fluctuations in serum cytokine levels in the patients with cyclic neutropenia. Am. J. Hematol. 39 (2): 144-145, 1992.
15. Memepel K., Pietsch T., Menzel T., Zeidler C., Welte K.: Increased serum levels granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 77 (9): 1919-1922, 1991.
16. Corbacioglu S., Bux J., Koning A., Gabrilove J.L., Welte K., Bussel J.B.: Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy. J. Pediatr. 137 (1):96-99, 2000.
17. Layton J.E., Cebon J.S., Morstyn G.: Cytokine responses to febrile neutropenia. Exp. Hematol. 19:506, 1991.
18. Kawakami M., Tsutsumi H., Kumakawa T., et al.: Levels of serum granulocyte colony-stimulating factor in patients with infections. Blood 76: 1962-1964, 1990.
19. Lieschke G.J, Grail D., Hodgson G.: Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage grogenitor cell deficiency and impaired neutrophil mobilization. Blood 84: 1737-1746, 1994.
20. Price T.H., Chatta G.S., Dale D.C.: Effect of recombinant granulocyte colony-stimulating factor on Neutrophil Kinetics in normal young and elderly humans. Blood 88: 335-340, 1996.
21. Kojima S., Matsuyama T., Kodena Y., et al.: Measurement of endogenuous plasma granulocyte colony-stimulating factor in patients with acquired aplastic anemia by a sensitive chemiluminescent immunoassay. Blood 87: 1303-1308, 1996.
22. Hartwig U.F., Keller U., Huber C., et al.: Regulation of hematopoietic growth factor production by genetically modified human bone marrow stromal cells expressing interleukin-1beta antisense RNA. J. Interferon Cytokine Res. 21 (10):851860, 2001.
23. Karsunky H., Zeng H., Schmidt T., et al.: Inflammatory reactions and severe neutropenia in mice lacking the transcriptional repressor Gfil. Nat. Genet. 28(1) [epub ahead of print]. 2002.
24. Weiss M., Fischer G., Barth E., et al.: Dissociation of LPS-induced monocytic ex vivo production of granulocyte colonystimulating factor (G-CSF) and TNF-alpha in patients with septic shock. Cytokine 13 (1): 51-54, 2001.